Targeting Two Antigens Associated with B-ALL with CD19-CD123 Compound Car T Cell Therapy-Reference-Cited by-同舟云学术

Targeting Two Antigens Associated with B-ALL with CD19-CD123 Compound Car T Cell Therapy

Published:2020-01-22 Issue:2 Volume:16 Page:385-396
ISSN:2629-3269
Container-title:Stem Cell Reviews and Reports
language:en
Short-container-title:Stem Cell Rev and Rep

Author:

Yan Lulu E.,Zhang Hongyu,Wada Masayuki,Fang Liu,Feng Jia,Zhang Wenli,Chen Qi,Cao Yuanzhen,Pinz Kevin G.,Chen Kevin H.,Petrov Jessica C.,Chen Xi,Leung Lai-Han,Fan Xing-Xing,Senzel Lisa,Jiang Xun,Ma Yupo^ORCID,Tse William

Funder

iCell Gene Therapeutics, LLC

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1007/s12015-019-09948-6.pdf

Reference20 articles.

1. Cobaleda, C., & Sánchez-García, I. (2009). B-cell acute lymphoblastic leukaemia: Towards understanding its cellular origin. BioEssays., 31(6), 600–609.

2. Typical Treatment of Acute Lymphocytic Leukemia: American Cancer Society; 2016 [Available from: https://www.cancer.org/cancer/acute-lymphocytic-leukemia/treating/typical-treatment.html.

3. Gaynon, P. S., Angiolillo, A. L., Carroll, W. L., Nachman, J. B., Trigg, M. E., Sather, H. N., et al. (2010). Long term results of the Children’s Cancer group studies for childhood acute lymphoblastic leukemia 1983–2002: a Children’s oncology group report. Leukemia., 24(2), 285–297.

4. Oriol, A., Vives, S., Hernández-Rivas, J.-M., Tormo, M., Heras, I., Rivas, C., Bethencourt, C., Moscardó, F., Bueno, J., Grande, C., del Potro, E., Guardia, R., Brunet, S., Bergua, J., Bernal, T., Moreno, M. J., Calvo, C., Bastida, P., Feliu, E., Ribera, J. M., & Programa Español de Tratamiento en Hematologia Group. (2010). Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA study group. Haematologica., 95(4), 589–596.

5. Maude, S. L., Frey, N., Shaw, P. A., Aplenc, R., Barrett, D. M., Bunin, N. J., et al. (2014). Chimeric antigen receptor T cells for sustained remissions in leukemia. The New England Journal of Medicine, 371(16), 1507–1517.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chimeric Antigen Receptor-T Cell Therapy for Lymphoma: New Settings and Future Directions;Cancers;2023-12-21

2. Tumor Microenvironment: A Niche for Cancer Stem Cell Immunotherapy;Stem Cell Reviews and Reports;2023-10-20

3. CAR T-Cells in Acute Lymphoblastic Leukemia: Current Status and Future Prospects;Biomedicines;2023-10-02

4. Multi-targeted immunotherapeutics to treat B cell malignancies;Journal of Controlled Release;2023-06

5. Cmpd10357 to treat B-cell acute lymphoblastic leukemia;Experimental Hematology;2023-03